1.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474
2.
3.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016-11, Vol.102 (21), p.1750-1756
4.
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
by Fransen, Marlene
Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.851-858
5.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
6.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and...
by Van Der Leeuw, Joep
Hypertension (Dallas, Tex. 1979), 2015-01-01, Vol.65 (1), p.115-121
Filter electronic articles 6 Hits
Remove Filters
-
Subjects: Aged
-
Subjects: Treatment Outcome
-
Subjects: Life Sciences & Biomedicine
-
Subjects: Risk Factors
- Subjects
- Treatment Outcome
- Aged
- Risk Factors
- more ...
- Science & Technology (6)
- Male (6)
- Life Sciences & Biomedicine
- Humans (6)
- Middle Aged (5)
- Female (5)
- Mortality (3)
- Type 2 Diabetes (3)
- Medicine (3)
- Cardiovascular System & Card... (3)
- Internal Medicine (3)
- Diabetes Mellitus, Type 2 - Comp... (3)
- Diabetes Mellitus, Type 2 - Drug... (3)
- Blood Circulation Disorders (2)
- Blood And Lymphatic Vessels (2)
- Adult (2)
- Biological And Medical Sciences (2)
- less ...